<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02407795</url>
  </required_header>
  <id_info>
    <org_study_id>NL45994.091.14</org_study_id>
    <nct_id>NCT02407795</nct_id>
  </id_info>
  <brief_title>Conventional With Stereotactic Radiotherapy for Pain Reduction and Quality of Life in Spinal Metastases</brief_title>
  <acronym>RACOST</acronym>
  <official_title>A RAndomized Trial Comparing COnventional With STereotactic Radiotherapy for Pain Reduction and Quality of Life in Spinal Metastases (RACOST-trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Koningin Wilhelmina Fonds</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maastro Clinic, The Netherlands</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized, multicentre, phase III study comparing conventional radiotherapy (1x8Gy) with
      stereotactic radiotherapy (1x20Gy) for pain reduction and quality of life in spinal
      metastases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study population: patients with painful spinal metastases from solid tumors without spinal
      cord compression or cord instability.

      Objective: This study will test the hypothesis that stereotactic radiotherapy gives a better
      and longer lasting reduction of pain, local control and therewith a better quality of life.
      This in order to optimize and to individualize the treatment options for the patient.

      Study design: Complaints due to pain will be analysed using the validated Dutch Brief Pain
      Inventory (BPI) and side-effects will be recorded using the Common Toxicity Criteria for
      Adverse Events (CTCAE). In addition to this the quality of life will be analysed using the
      EORTC QOL-C15-PAL and EORTC QLQ-BM22 questionnaires. For analysis of cost-effectiveness the
      EQ-5D will be used.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain reduction measured by the Dutch Brief Pain Inventory (BPI) questionnaire</measure>
    <time_frame>At six weeks since baseline</time_frame>
    <description>Pain is self-reported and measured by the validated Dutch Brief Pain Inventory (BPI) questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of time to pain response</measure>
    <time_frame>pain response is calculated from the date of randomization at day 0-14, week 4, 6, and month 2, 3, 4, 6, 9, and 12</time_frame>
    <description>Pain is self-reported and measured by the validated Dutch Brief Pain Inventory (BPI) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of pain relief</measure>
    <time_frame>Pain relief is calculated from the date of randomization at day 0-14, week 4, 6, and month 2, 3, 4, 6, 9, and 12</time_frame>
    <description>Pain is self-reported and measured by the validated Dutch Brief Pain Inventory (BPI) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Quality of life is calculated from the date of randomization at day 0, 7, 14, week 4, 6, and month 2, 3, 4, 6, 9, and 12</time_frame>
    <description>EORTC QOL-C15-PAL and EORTC QLQ-BM22 questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toxicity measured by CTCAE 4.0 questionnaire</measure>
    <time_frame>up to months 12</time_frame>
    <description>Toxicity measuredCTCAE 4.0 questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Spinal Metastases</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional radiotherapy, 1x8Gy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stereotactic radiotherapy, 1x20Gy</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>conventional radiotherapy</intervention_name>
    <description>1x8Gy</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>stereotactic radiotherapy</intervention_name>
    <description>1x20Gy or equivalent dose fractionation schedule</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  solid tumor with radiological diagnosis of spinal metastases

          -  pain score minimum 2 on 11-point scale

          -  maximum of 2 consecutive or noncontiguous spinal vertebra involved by tumor at current
             level of interest

          -  No or mild neurological signs (radiculopathy, dermatomal sensory change and muscle
             strength of involved extremity)

          -  Karnofsky performance ≥60

          -  WHO ≤2

          -  life expectancy &gt; 6 weeks

          -  age ≥18

          -  non-pregnant, non-lactating female patients

        Exclusion Criteria:

          -  history of previous radiotherapy to the spine at current level of interest

          -  spinal instability or neurological deficit

          -  pathological fracture or impending fracture needing fixation

          -  prior surgery to the spine at current level of interest

          -  clinical signs of spinal cord compression or severe neurological deficits

          -  patients with a pacemaker such that MRI cannot be performed or the treatment cannot be
             delivered safely

          -  patients unable to undergo MRI

          -  earlier nuclear medicine treatment

          -  pregnancy

          -  altered mental status that would prohibit the understanding and giving of informed
             consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>P Braam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboudumc Nijmegen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radiotherapiegroep Arnhem</name>
      <address>
        <city>Arnhem</city>
        <zip>6815 AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Haaglanden</name>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiotherapiegroep Deventer</name>
      <address>
        <city>Deventer</city>
        <zip>7416 SE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MAASTRO clinic</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 ET</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radboudumc Nijmegen</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Isala</name>
      <address>
        <city>Zwolle</city>
        <zip>8025 AB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2015</study_first_submitted>
  <study_first_submitted_qc>April 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2015</study_first_posted>
  <last_update_submitted>January 25, 2018</last_update_submitted>
  <last_update_submitted_qc>January 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stereotactic radiotherapy</keyword>
  <keyword>pain reduction</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

